Document Detail

A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide.
MedLine Citation:
PMID:  16284426     Owner:  NLM     Status:  MEDLINE    
Major causes of fasting hypoglycemia in adults are insulinoma, factitious hypoglycemia and nesidioblastosis. The primary treatment for insulinoma is surgical removal of the tumor, but there are cases with hyperinsulinemia that cannot undergo surgery. Somatostatin analogue is one of the treatments used in such cases of insulinoma or persistent hyperinsulinemic hypoglycemia. We report here a patient who had undetermined hyperinsulinemia and was successfully treated with a long-acting somatostatin analogue, which had recently become available. The patient, a 72-year-old female, who had previously been diagnosed as insulinoma and undergone partial pancreatectomy, was admitted complaining of the recurrence of hypoglycemic attacks after an interval of ten years. On admission, hypoglycemia (42 mg/dl), hyperinsulinemia (IRI: 79.3 microU/m) and low HbA1c (3.6%) were present. In 75 g-OGTT at 30 min after load, IRI reached 6623 microU/ml, while plasma glucose level was 88 mg/dl. The anti-insulin antibody was not present. Since attempts at tumor localization by imaging techniques failed and the patient refused further examinations or surgical treatment, we recommended her to take a medication with a somatostatin analogue. Insulin suppression test using 50 microg of octreotide improved plasma glucose and IRI levels, suggesting the usefulness of the treatment, and a monthly administration of 20 mg of long-acting octreotide has successfully controlled her symptoms of hypoglycemia for 10 months. Our case demonstrated the utility of the long-acting somatostatin analogue for long-term treatment of undetermined hyperinsulinemia. A preliminary loading test using short-acting octreotide may be useful to determine appropriate medication, especially in cases who cannot receive surgical treatment.
Tatsuya Kondo; Saori Tomita; Hironori Adachi; Hiroyuki Motoshima; Kayo Taketa; Akiko Matsuyoshi; Hiroshi Tokunaga; Nobuhiro Miyamura; Eiichi Araki
Related Documents :
24494046 - Vitamin d status and sun exposure in india.
18682516 - Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas.
10690616 - The effect of albendazole on the prevention of secondary hydatidosis.
19568466 - Cyst ablation using a mixture of n-butyl cyanoacrylate and iodized oil in patients with...
7375956 - Calcification in the soft tissues of the chest after thoracotomy.
17496586 - Completely autologous platelet gel in breast reduction surgery: a blinded, randomized, ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Endocrine journal     Volume:  52     ISSN:  0918-8959     ISO Abbreviation:  Endocr. J.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-11-14     Completed Date:  2006-01-26     Revised Date:  2006-02-24    
Medline Journal Info:
Nlm Unique ID:  9313485     Medline TA:  Endocr J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  511-7     Citation Subset:  IM    
Department of Metabolic Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / analysis
Delayed-Action Preparations
Hemoglobin A, Glycosylated / analysis
Hyperinsulinism / drug therapy*
Insulin / blood
Octreotide / administration & dosage*,  diagnostic use
Reg. No./Substance:
0/Blood Glucose; 0/Delayed-Action Preparations; 0/Hemoglobin A, Glycosylated; 11061-68-0/Insulin; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in chil...
Next Document:  Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children.